Comment le bénéfice par action récent de TMDX se compare-t-il aux attentes ?
Comment les revenus de Transmedics Group Inc TMDX se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Transmedics Group Inc ?
Quel est le score de qualité des bénéfices pour Transmedics Group Inc ?
Quand Transmedics Group Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Transmedics Group Inc ?
Transmedics Group Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$135.3
Prix d'ouverture
$134.9
Plage de la journée
$132.81 - $138.68
Plage de 52 semaines
$59.23 - $156
Volume
146.9K
Volume moyen
845.9K
BPA (TTM)
2.30
Rendement en dividend
--
Capitalisation boursière
$4.7B
Qu’est-ce que TMDX ?
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 728 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.